Back to Pharmacology Lesson preview
Pharmacology Drugs Used in Asthma

Pathophysiology of Asthma and COPD

Topic overview

Start with the big picture

Asthma is characterized by episodic, largely reversible obstruction associated with Th2-mediated eosinophilic inflammation and IgE. Mast-cell mediators can produce bronchoconstriction, while edema and mucus contribute to airway narrowing; persistent disease may remodel the airway. COPD is generally less reversible and strongly associated with smoking. Neutrophils, macrophages, and CD8⁺ T cells contribute to tissue injury, while reduced elastic recoil, airway collapse, mucus, and fibrosis restrict airflow. The diseases also differ in steroid responsiveness: asthma is generally steroid-sensitive, whereas COPD has a more limited response. This preview frames the key mechanisms and therapeutic rationales; the full lesson develops their distinctions and clinical relevance in greater detail.

Learning objectives

What you'll learn

  • Describe the Th2- and IgE-mediated inflammatory pathway in asthma.
  • Identify how asthma mediators and airway changes contribute to obstruction.
  • Explain the inflammatory profile and airflow-limiting mechanisms of COPD.
  • Compare asthma and COPD in reversibility and steroid responsiveness.
  • Relate selected disease mechanisms to therapeutic targets.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits